NOVEN

Serial Number 73839221
Registration 1603381
800

Registration Progress

Application Filed
Nov 14, 1989
Under Examination
Approved for Publication
Mar 3, 1990
Published for Opposition
Apr 3, 1990
Registered
Jun 26, 1990

Basic Information

Serial Number
73839221
Registration Number
1603381
Filing Date
November 14, 1989
Registration Date
June 26, 1990
Published for Opposition
April 3, 1990
Renewal Date
June 26, 2020
Drawing Code
1000

Status Summary

Current Status
Active
Status Code
800
Status Date
Apr 8, 2020
Registration
Registered
Classes
005

Rights Holder

NOVEN PHARMACEUTICALS, INC.

03
Address
11960 S.W. 144TH STREET
MIAMI, FL 33186

Ownership History

NOVEN PHARMACEUTICALS, INC.

Original Applicant
03
MIAMI, FL

NOVEN PHARMACEUTICALS, INC.

Owner at Publication
03
MIAMI, FL

NOVEN PHARMACEUTICALS, INC.

Original Registrant
03
MIAMI, FL

Legal Representation

Attorney
Norm J. Rich

USPTO Deadlines

Next Deadline
1813 days remaining
Section 8 & 9 (40-Year) Renewal Due (Based on registration date 1990-06-26)
Due Date
June 26, 2030
Grace Period Ends
December 26, 2030

Application History

29 events
Date Code Type Description
Apr 8, 2020 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 8, 2020 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Apr 8, 2020 RNL3 Q REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)
Apr 8, 2020 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Feb 12, 2020 E89R I TEAS SECTION 8 & 9 RECEIVED
Jun 26, 2019 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jun 24, 2010 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Jun 24, 2010 RNL2 Q REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Jun 22, 2010 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 10, 2010 E89R I TEAS SECTION 8 & 9 RECEIVED
Dec 31, 2008 CFIT O CASE FILE IN TICRS
Sep 19, 2006 PLGL A ASSIGNED TO PARALEGAL
Sep 19, 2006 8.OK O REGISTERED - SEC. 8 (6-YR) ACCEPTED
Jun 26, 2006 ES8R I TEAS SECTION 8 RECEIVED
Jun 26, 2006 8.AF I REGISTERED - SEC. 8 (6-YR) FILED
May 23, 2001 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
May 23, 2001 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Jan 30, 2001 PR89 I RESPONSE RECEIVED TO POST REG. ACTION - SEC. 8 & 9
Jan 25, 2001 PR89 O POST REGISTRATION ACTION MAILED - SEC. 8 & 9
May 30, 2000 89AF I REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
Jun 2, 1996 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Oct 31, 1995 815F I REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Jun 26, 1990 R.PR A REGISTERED-PRINCIPAL REGISTER
Apr 3, 1990 PUBO A PUBLISHED FOR OPPOSITION
Mar 3, 1990 NPUB O NOTICE OF PUBLICATION
Jan 25, 1990 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 22, 1990 CNEA F EXAMINER'S AMENDMENT MAILED
Jan 22, 1990 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 10, 1990 DOCK D ASSIGNED TO EXAMINER

Detailed Classifications

Class 005
TRANSDERMALLY - DELIVERED HORMONAL THERAPY
First Use Anywhere: Oct 12, 1989
First Use in Commerce: Oct 12, 1989

Classification

International Classes
005